Literature DB >> 33414995

The effect of hepatocellular carcinoma-associated fibroblasts on hepatoma vasculogenic mimicry.

Qin She1, Shuya Hu2, Xia Pu1, Qingxi Guo1, Chunru Mou1, Chengwan Yang1.   

Abstract

Vasculogenic Mimicry (VM) is the main source of blood supply in the early stage of tumor growth. Carcinoma-associated fibroblasts (CAFs) are one of the most important host cells in the tumor microenvironment. Some studies have found that CAFs can promote tumor angiogenesis, but there are few reports on the relationship between CAFs and VM. Tissue samples were collected from 60 cases of hepatocellular carcinoma (HCC) and 10 persons with normal liver function. The relationship between VM expression and clinicopathologic features was analyzed. Furthermore, the relationship between VM expression and vimentin or α-SMA expression was analyzed. Primary culture of hepatocellular CAFs and the collection of conditioned media were carried out. The effects of hepatocellular CAF conditioned medium on the formation of VM and the levels of VM-related proteins and genes in MHCC-97H cells were studied. The positive rate of VM was 35.0% in HCC tissues. There was no VM expression in normal liver tissues. VM expression was related to tumor diameter, Edmondson grade, clinical stage, and liver cirrhosis. The expression of vimentin and α-SMA in VM-positive patients was higher than in VM-negative patients. Different concentrations of hepatocellular CAF conditioned medium could promote the formation of VM and increase the expression of VM-related genes and proteins (MMP2 and EphA2) in MHCC-97H cells. The results show that there was a significant correlation between VM formation and the expression of vimentin or α-SMA in HCC tissues. The conditioned medium of hepatocellular CAFs may promote VM formation and the expression of VM-related genes and proteins (MMP2 and EphA2) in hepatoma cell line MHCC-97H. AJCR
Copyright © 2020.

Entities:  

Keywords:  Hepatocellular carcinoma; carcinoma-associated fibroblasts; vasculogenic mimicry

Year:  2020        PMID: 33414995      PMCID: PMC7783763     

Source DB:  PubMed          Journal:  Am J Cancer Res        ISSN: 2156-6976            Impact factor:   6.166


  39 in total

1.  RhoC/ROCK2 promotes vasculogenic mimicry formation primarily through ERK/MMPs in hepatocellular carcinoma.

Authors:  Ji-Gang Zhang; Dan-Dan Zhang; Ying Liu; Juan-Ni Hu; Xue Zhang; Li Li; Wan Mu; Guan-Hua Zhu; Qin Li; Gao-Lin Liu
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2019-02-16       Impact factor: 5.187

2.  ZEB2 promotes vasculogenic mimicry by TGF-β1 induced epithelial-to-mesenchymal transition in hepatocellular carcinoma.

Authors:  Zhihong Yang; Baocun Sun; Yanlei Li; Xiulan Zhao; Xueming Zhao; Qiang Gu; Jindan An; Xueyi Dong; Fang Liu; Yong Wang
Journal:  Exp Mol Pathol       Date:  2015-03-26       Impact factor: 3.362

Review 3.  The evolving epidemiology of hepatocellular carcinoma: a global perspective.

Authors:  Michael C Wallace; David Preen; Gary P Jeffrey; Leon A Adams
Journal:  Expert Rev Gastroenterol Hepatol       Date:  2015-04-01       Impact factor: 3.869

4.  Akt-Girdin signaling in cancer-associated fibroblasts contributes to tumor progression.

Authors:  Yumiko Yamamura; Naoya Asai; Atsushi Enomoto; Takuya Kato; Shinji Mii; Yuji Kondo; Kaori Ushida; Kaoru Niimi; Nobuyuki Tsunoda; Masato Nagino; Shu Ichihara; Koichi Furukawa; Kengo Maeda; Toyoaki Murohara; Masahide Takahashi
Journal:  Cancer Res       Date:  2015-03-01       Impact factor: 12.701

5.  Ginsenoside Rg3 inhibition of vasculogenic mimicry in pancreatic cancer through downregulation of VE‑cadherin/EphA2/MMP9/MMP2 expression.

Authors:  Jing-Qiang Guo; Qing-Hui Zheng; Hui Chen; Liang Chen; Jin-Bo Xu; Min-Yuan Chen; Dian Lu; Zhao-Hong Wang; Hong-Fei Tong; Shengzhang Lin
Journal:  Int J Oncol       Date:  2014-06-16       Impact factor: 5.650

6.  Cancer-associated fibroblasts promote hepatocellular carcinoma metastasis through chemokine-activated hedgehog and TGF-β pathways.

Authors:  Jiao Liu; Sheng Chen; Wei Wang; Bei-Fang Ning; Fei Chen; Weifeng Shen; Jin Ding; Wansheng Chen; Wei-Fen Xie; Xin Zhang
Journal:  Cancer Lett       Date:  2016-05-20       Impact factor: 8.679

7.  Vasculogenic Mimicry in Prostate Cancer: The Roles of EphA2 and PI3K.

Authors:  Hua Wang; Hao Lin; Jincheng Pan; Chengqiang Mo; Faming Zhang; Bin Huang; Zongren Wang; Xu Chen; Jintao Zhuang; Daohu Wang; Shaopeng Qiu
Journal:  J Cancer       Date:  2016-06-05       Impact factor: 4.207

8.  Down-regulation of miR-29b in carcinoma associated fibroblasts promotes cell growth and metastasis of breast cancer.

Authors:  Yonglei Liu; Jingling Zhang; Xiangjun Sun; Quanping Su; Cuiping You
Journal:  Oncotarget       Date:  2017-06-13

Review 9.  Vasculogenic mimicry signaling revisited: focus on non-vascular VE-cadherin.

Authors:  Daniel Delgado-Bellido; Santiago Serrano-Saenz; Mónica Fernández-Cortés; F Javier Oliver
Journal:  Mol Cancer       Date:  2017-03-21       Impact factor: 27.401

10.  Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer.

Authors:  Daniel Öhlund; Abram Handly-Santana; Giulia Biffi; Ela Elyada; Ana S Almeida; Mariano Ponz-Sarvise; Vincenzo Corbo; Tobiloba E Oni; Stephen A Hearn; Eun Jung Lee; Iok In Christine Chio; Chang-Il Hwang; Hervé Tiriac; Lindsey A Baker; Dannielle D Engle; Christine Feig; Anne Kultti; Mikala Egeblad; Douglas T Fearon; James M Crawford; Hans Clevers; Youngkyu Park; David A Tuveson
Journal:  J Exp Med       Date:  2017-02-23       Impact factor: 14.307

View more
  1 in total

Review 1.  Non-coding RNAs in lung cancer: emerging regulators of angiogenesis.

Authors:  Yajie Liao; Xudong Wu; Mengyu Wu; Yuan Fang; Jie Li; Weiqiang Tang
Journal:  J Transl Med       Date:  2022-08-02       Impact factor: 8.440

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.